Ticker ARPO – Aerpio Pharma – sales, description, marketcap – Tickerday.com

ARPO

Aerpio Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 62.47M; Volume: 886.57K; AvgVol 3m: 2.11M; Beta: –;

Cost estimate:

P/E: –; EPS: -0.46; EPS growth quarter/prev quarter: 261.90%;

EPS growth this year: -87.10%; EPS growth past 5 years: ;

EPS ttm: -0.09;

P/S: 04.09; P/B: 1.34; P/Cashflow: 1.37; P/FCF: ;

Sales: 15.00M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: -24.90%; Operating Margin: ;

ROA – return on assets: -9.00%; ROE – return on equity: -9.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 24.32%; Insider Transactions:0.00%;

Institutional Ownership: 27.30%; Institutional Transactions: 15.29%;

Data update: 07.10.2020.